RENAL HEMODYNAMICS OF CYCLOSPORINE-A NEPHROTOXICITY IN CHILDREN WITH JUVENILE DERMATOMYOSITIS

被引:11
|
作者
PETERS, AM
HECKMATT, JZ
HASSON, N
HENDERSON, BL
ELMELEIGY, D
ROSE, ML
DUBOWITZ, V
机构
[1] HAMMERSMITH HOSP,DEPT PAEDIAT,LONDON W12 0HS,ENGLAND
[2] HAREFIELD HOSP,DEPT THORAC & CARDIAC SURG,HAREFIELD,MIDDX,ENGLAND
关键词
CYCLOSPORINE; DERMATOMYOSITIS; RENAL HEMODYNAMICS; TC-99M-LABELED DIETHYLENETRIAMINEPENTAACETATE;
D O I
10.1042/cs0810153
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1. Renal haemodynamics were monitored over an average period of 19 months in 17 children being treated with cyclosporin A. Sixteen had juvenile dermatomyositis and one had chronic polyneuropathy. The dose of cyclosporin A ranged from 2.3 to 8.3 mg day-1 kg-1 (median 4.1 mg day-1 kg-1). 2. Glomerular filtration rate (expressed in terms of extracellular fluid volume), renal blood flow (expressed as a fraction of cardiac output) and filtration fraction were measured by using Tc-99m-labelled diethylenetriamine-penta-acetate. They were compared with the dosage and trough blood levels of cyclosporin A, and, in 15 patients receiving prednisolone in addition to cyclosporin A, with steroid dosage. 3. All 17 children had a renogram performed 6 months after starting cyclosporin A treatment. Nine of them also had a renogram before starting cyclosporin A treatment (baseline study), while 13, in addition to their renogram 6 months after starting cyclosporin A treatment, also had at least one further renogram. 4. Glomerular filtration rate/extracellular fluid volume fell slightly but significantly from 0.009 (SD 0.0013) before starting cyclosporin A treatment to 0.0085 (0.002) min-1 (P < 0.01) 6 months after cyclosporin A treatment in the nine children who underwent a baseline study. This was accompanied by a significant (P < 0.001) fall in filtration fraction from 0.108 (0.015) to 0.088 (0.014). However, renal blood flow/cardiac output showed no change. 5. In the 13 children studied beyond 6 months after starting cyclosporin A treatment, there was no further significant overall change in any renal haemodynamic variable. However, throughout this period, trough blood levels of cyclosporin A, which ranged from 20 to 258 ng/ml (median 67 ng/ml), correlated inversely with glomerular filtration rate/extracellular fluid volume, but not with renal blood flow/cardiac output. Furthermore, although a weak correlation between filtration fraction and trough blood levels of cyclosporin A did not reach statistical significance, sequential changes in filtration fraction correlated significantly with corresponding sequential changes in glomerular filtration rate/extracellular fluid volume. 6. We conclude that the predominant mechanism of renal impairment at these relatively low trough blood levels of cyclosporin A is a reversible reduction in filtration fraction.
引用
收藏
页码:153 / 159
页数:7
相关论文
共 50 条
  • [21] CYCLOSPORINE-A AS FIRST CHOICE THERAPY FOR DERMATOMYOSITIS
    GRAU, JM
    HERRERO, C
    CASADEMONT, J
    FERNANDEZSOLA, J
    URBANOMARQUEZ, A
    JOURNAL OF RHEUMATOLOGY, 1994, 21 (02) : 381 - 382
  • [22] NEPHROTOXICITY OF CYCLOSPORINE-A AND CYCLOSPORINE-G IN A RAT MODEL
    TEJANI, A
    LANCMAN, I
    POMRANTZ, A
    KHAWAR, M
    CHEN, C
    TRANSPLANTATION, 1988, 45 (01) : 184 - 187
  • [23] DOES NIFEDIPINE AMELIORATE CYCLOSPORINE-A NEPHROTOXICITY
    FEEHALLY, J
    WALLS, J
    MISTRY, N
    HORSBURGH, T
    TAYLOR, J
    VEITCH, PS
    BELL, PRF
    BRITISH MEDICAL JOURNAL, 1987, 295 (6593): : 310 - 310
  • [24] CYCLOSPORINE NEPHROTOXICITY - BLOOD-VOLUME, SODIUM CONSERVATION, AND RENAL HEMODYNAMICS
    DEVARAJAN, P
    KASKEL, FJ
    ARBEIT, LA
    MOORE, LC
    AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (01): : F71 - F78
  • [25] DOES NIFEDIPINE AMELIORATE CYCLOSPORINE-A NEPHROTOXICITY
    KWAN, JTC
    FOXALL, PJD
    TOWNEND, JN
    BENDING, MR
    EISINGER, AJ
    BRITISH MEDICAL JOURNAL, 1987, 295 (6602): : 851 - 851
  • [26] FUNCTIONAL AND HISTOPATHOLOGICAL CYCLOSPORINE-A NEPHROTOXICITY IN CHILDREN AFTER ORGAN-TRANSPLANTATION
    LAINE, J
    JALANKO, H
    KROGERUS, L
    FYHRQUIST, F
    RONNHOLM, K
    LEIJALA, M
    HOCKERSTEDT, K
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 1131 - 1133
  • [27] JUVENILE DERMATOMYOSITIS TREATED WITH CYCLOSPORINE
    DANTZIG, P
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990, 22 (02) : 310 - 311
  • [28] NEPHROTOXICITY OF FK506 VERSUS CYCLOSPORINE-A AFTER RENAL-TRANSPLANTATION
    CHRISTIAANS, MHL
    SPIERING, W
    NIEMAN, F
    VANHOOFF, JP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 1078 - 1078
  • [29] CYCLOSPORINE-A (CSA) AND AZATHIOPRINE (AZA) COMBINATION IN RENAL-ALLOGRAFTS WITH CSA NEPHROTOXICITY
    CASTELAO, AM
    GRINO, JM
    SABATE, I
    SERON, D
    ANDRES, E
    GILVERNET, S
    BOVER, J
    GONZALEZ, C
    ALSINA, J
    TRANSPLANT INTERNATIONAL, 1992, 5 : S58 - S59
  • [30] TOLERANCE OF CYCLOSPORINE-A IN CHILDREN WITH REFRACTORY JUVENILE RHEUMATOID-ARTHRITIS
    OSTENSEN, M
    HOYERAAL, HM
    KASS, E
    JOURNAL OF RHEUMATOLOGY, 1988, 15 (10) : 1536 - 1538